How much is a share of laboratory stock worth?
One share of LH stock can currently be purchased for approximately $304.88. How much money does Laboratory Co. of America make? Laboratory Co. of America has a market capitalization of $29.39 billion and generates $13.98 billion in revenue each year.
Should value investors pick Laboratory Corporation of America Holdings (LH) stock?
Let’s put Laboratory Corporation of America Holdings LH or LabCorp stock into this equation and find out if it is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks: A key metric that value investors always look at is the Price to Earnings Ratio, or PE for short.
What is the beta of Laboratory Corporation of America stock?
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Laboratory Corporation of America's is 1. 0576.
What is the ticker symbol for laboratory co of America?
Laboratory Co. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH." Who are Laboratory Co. of America's major shareholders? Laboratory Co. of America's stock is owned by a variety of institutional and retail investors.
Can I buy stock in labcorp?
How do I become a LabCorp Investor? Any brokerage, bank or other entity authorized to trade in shares of publicly held securities can assist you with purchasing LH shares. LH currently does not offer a direct stock purchase program through the company.
Is labcorp publicly traded?
Is Labcorp a public organization? Yes. Laboratory Corporation of America Holdings is listed on the New York Stock Exchange (NYSE) under ticker symbol LH.
Is labcorp a dividend stock?
7, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors (the Board) has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on June 9, 2022 , to stockholders of record as of the close of business on May 19, 2022 .
What is labcorp net worth?
(NGI), in Los Angeles, California, which develops PCR testing methods....Labcorp.Labcorp logo updated December 2020TypePublicNet incomeUS$ 2.38 billion (2021)Total assetsUS$ 20.30 billion (2021)Total equityUS$ 10.27 billion (2021)11 more rows
Who is LabCorp owned by?
Hoffmann-La Roche merges all of its laboratory companies into one company, now called Roche Biomedical Laboratories (RBL).
How much is a LabCorp franchise?
Facts & FiguresLiquid capital required$90,000Franchise fee$40,000Royalty8.0%Offers FinancingYesUnits in operation1952 more rows
Who is bigger quest or LabCorp?
For years, Quest was the largest, but LabCorp took over that spot a few years ago. Both companies are noted for growth through acquisition, and 2017 has been a very big year for LabCorp. Since 2008, LabCorp has acquired 19 companies.
Is LabCorp a good company?
LabCorp has an overall rating of 3.5 Average Rating out of 5, based on over 37 LabCorp Review Ratings left anonymously by LabCorp employees, which is 10% lower than the average rating for all companies on CareerBliss. 78% of employees would recommend working at LabCorp.
Does quest own LabCorp?
LabCorp and Quest Diagnostics are publicly-traded companies but they have different subsidiaries, which specialize in various protocols.
Should I buy or sell Laboratory Co. of America stock right now?
7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Laboratory Co. of America in the last year. There are cu...
What is Laboratory Co. of America's stock price forecast for 2022?
7 brokers have issued 1 year target prices for Laboratory Co. of America's shares. Their forecasts range from $235.00 to $350.00. On average, they...
How has Laboratory Co. of America's stock price performed in 2022?
Laboratory Co. of America's stock was trading at $314.21 on January 1st, 2022. Since then, LH shares have decreased by 28.6% and is now trading at...
Are investors shorting Laboratory Co. of America?
Laboratory Co. of America saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 1,240,000 shares,...
When is Laboratory Co. of America's next earnings date?
Laboratory Co. of America is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecas...
How were Laboratory Co. of America's earnings last quarter?
Laboratory Co. of America Holdings (NYSE:LH) issued its quarterly earnings results on Thursday, April, 28th. The medical research company reported...
How often does Laboratory Co. of America pay dividends? What is the dividend yield for Laboratory Co. of America?
Laboratory Co. of America announced a quarterly dividend on Thursday, April 7th. Shareholders of record on Thursday, May 19th will be given a divid...
Is Laboratory Co. of America a good dividend stock?
Laboratory Co. of America(NYSE:LH) pays an annual dividend of $2.88 per share and currently has a dividend yield of 1.21%. The dividend payout rati...
What guidance has Laboratory Co. of America issued on next quarter's earnings?
Laboratory Co. of America updated its FY 2022 earnings guidance on Monday, May, 9th. The company provided earnings per share (EPS) guidance of $18....
When will Labcorp release its results?
Is LabCorp merging with Syneos?
BURLINGTON, N.C., July 02, 2021--Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the second quarter of 2021 before the market opens on Thursday, July 29, 2021. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings release and accompanying financial information will be posted on the Labcorp Investor Relations website.
Labcorp, Quidel: Omicron Brings Covid Testing Stocks Back In Focus
The companies are discussing a deal in which part of LabCorp's Covance clinical research division would merge with Syneos. The sources said that the companies are discussing structuring the deal as a so-called Reverse Morris Trust, which provides tax benefits by spinning off an asset before it's combined. Blo
Is Quest Diagnostics Or LabCorp The Better Bet As Economy Opens
Our indicative theme on Covid-19 Testing Stocks – which includes companies that produce or carry out tests for Covid-19 infections - is up by 24% year-to-date, roughly in line with the S&P 500. While we were somewhat cautious about the long-term prospects for Covid-19 testing stocks in 2020...
More Medical Mega-Breaches Thanks To Third-Party Insecurity
As the U.S. re-opens its economy while trying to contain the spread of the contagious viral infection, demand for COVID testing is likely to soar and diagnostic companies such as Quest and LabCorp could be well-positioned to benefit, considering their vast testing infrastructure and footprint of...
Speculation Mounts About Walgreens Acquisition Targets
The compromise of the personal and medical information of nearly 20 million people held by Quest Diagnostics, LabCorp and Opko Health are just the latest illustration of the damage that a lack of security by third-party vendors can cause.
Walgreens, LabCorp To Open 600 Diagnostic Test Centers
Speculation is growing that Walgreens may buy the rest of AmerisourceBergen Corp. or diagnostic testing firm LabCorp.
Amazon May Push Walgreens To Expand UnitedHealth And LabCorp Deals
Walgreens said it will expand a collaboration with diagnostic testing firm LabCorp to open at least 600 patient service centers at Walgreens stores over the next four years.
UnitedHealth Signs Value-Based Lab Deals With Quest Diagnostics And LabCorp
Walgreens Boots Alliance may expand relationships with UnitedHealth Group's MedExpress urgent care unit and the diagnostic test firm LabCorp if investors have their way.
What is Laboratory Corp?
UnitedHealth Group has signed long-term value-based care contracts with Quest Diagnostics and LabCorp, large U.S. diagnostic test companies.
What is the ticker symbol for Laboratory Co. of America?
of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC.
How much does Laboratory Co. of America make?
Laboratory Co. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH.".
Where is the Laboratory Co of America located?
Laboratory Co. of America has a market capitalization of $27.46 billion and generates $13.98 billion in revenue each year. The medical research company earns $1.56 billion in net income (profit) each year or $23.94 on an earnings per share basis.
When is Laboratory Co of America's next earnings announcement?
Laboratory Co. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company can be reached via phone at 336-229-1127 or via email at [email protected].
Is Laboratory Co. of America a buy?
of America's next earnings date? Laboratory Co. of America is scheduled to release its next quarterly earnings announcement on Thursday, July 29th 2021. View our earnings forecast for Laboratory Co. of America.
Does Laboratory Co. of America pay dividends?
Laboratory Co. of America has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 11 buy ratings, no hold ratings, and no sell ratings.
New York Stock Exchange
Laboratory Co. of America does not currently pay a dividend.
News & Analysis: Laboratory Corporation of America
An independent clinical laboratory company that offers a range of clinical laboratory tests which are used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease.
Key Data Points
The Fool has written over 100 articles on Laboratory Corporation of America.
Environmental, Social, and Governance Rating
Primary metrics and data points about Laboratory Corporation of America.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
When was Laboratory Corporation of America Holdings last rated?
An independent clinical laboratory company that offers a range of clinical laboratory tests which are used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease.
What is Laboratory Corporation of America?
Laboratory Corporation of America Holdings was last rated for ESG on: 2019-01-01.
Is Laboratory Corporation of America stock undervalued or overvalued?
Laboratory Corporation of America Holdings is a diagnostics & research business based in the US. Laboratory Corporation of America shares (LH) are listed on the NYSE and all prices are listed in US Dollars. Laboratory Corporation of America employs 70,000 staff and has a trailing 12-month revenue of around 0.00.
What is the environmental score of Laboratory Corporation of America?
Valuing Laboratory Corporation of America stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Laboratory Corporation of America's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
How to calculate Laboratory Corporation's P/E ratio?
Laboratory Corporation of America's environmental score of 4.17 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Laboratory Corporation of America is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Can the value of an investment go up or down?
Laboratory Corporation of America's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0681. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
Is Robinhood a good trading app?
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
